Aim & Scope
Molecular Cancer is an open access, peer-reviewed journal interested in attracting high-quality original research and reviews that present or highlight significant advances in all areas of cancer and related biomedical science. Molecular Cancer provides an important forum for exciting findings in cancer-related research, presenting an unparalleled opportunity to communicate information to specialists and the public. The online appearance of Molecular Cancer allows the immediate publication of accepted articles and the presentation of large amounts of data and supplemental information to ensure that new research is disseminated as efficiently and quickly as possible to the scientific community. Molecular Cancer promotes the exchange of ideas, concepts and findings in any area of cancer and related biomedical science, from a molecular point of view. Molecular Cancer is interested in articles from basic, translational and clinical research, opening new avenues for the understanding, prevention, diagnosis and treatment of cancer. Topics of interest include, but are not limited to: cell and tumor biology, angiogenesis, animal models, metastasis, cancer antigens and the immune response to them, cellular signalling and molecular biology, epidemiology, genetic and molecular profiling of cancer and molecular targets, cancer stem cells, DNA damage and repair, cell cycle, apoptosis, molecular virology and vaccine- and antibody-based cancer therapies. [1]
2024 - VOLUME 23, ISSUE 1
K Yasui , T Toshima , R Inada , ... , T Nagasaka
Molecular Cancer , 2024 - VOLUME 23, ISSUE 1 , p 1.
0
20
Therapeutic challenges in peripheral T-cell lymphoma.
Y Luan , X Li , Y Luan , ... , DH Yang
Molecular Cancer , 2024 - VOLUME 23, ISSUE 1 , p 2.
Review
3
152
Correction: CMTM6 overexpression confers trastuzumab resistance in HER2‑positive breast cancer.
F Xing , H Gao , G Chen , ... , C Liu
Molecular Cancer , 2024 - VOLUME 23, ISSUE 1 , p 3.
0
1
Z Zheng , X Zeng , Y Zhu , ... , W Tan
Molecular Cancer , 2024 - VOLUME 23, ISSUE 1 , p 4.
3
46
H Li , R Lin , Y Zhang , ... , W Zhang
Molecular Cancer , 2024 - VOLUME 23, ISSUE 1 , p 5.
3
48
OL Gammelgaard , MG Terp , AF Kirkin , ... , HJ Ditzel
Molecular Cancer , 2024 - VOLUME 23, ISSUE 1 , p 6.
2
43
Multifaceted roles for BCL3 in cancer: a proto-oncogene comes of age.
G Seaton , H Smith , A Brancale , ... , R Clarkson
Molecular Cancer , 2024 - VOLUME 23, ISSUE 1 , p 7.
Review
0
148
Evolution of cell therapy for renal cell carcinoma.
Y Wang , ER Suarez , G Kastrunes , ... , WA Marasco
Molecular Cancer , 2024 - VOLUME 23, ISSUE 1 , p 8.
Review
7
141
M Chehelgerdi , M Chehelgerdi , M Khorramian-Ghahfarokhi , ... , A Mokhtari-Farsani
Molecular Cancer2024 - VOLUME 23, ISSUE 1 p 9.
9 330
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold.
T Schmäche , J Fohgrub , A Klimova , ... , DE Stange
Molecular Cancer , 2024 - VOLUME 23, ISSUE 1 , p 10.
3
15
Editorial Retractions, Expressions of Concern and External Notices
M Iida , TM Brand , MM Starr , ... , DL Wheeler
Molecular Cancer2014 - VOLUME 13, ISSUE 1 p 242.
35 52
S Markovina , NS Callander , SL O'Connor , ... , S Miyamoto
Molecular Cancer2010 - VOLUME 9, ISSUE 1 p 176.
67 45
M Chehelgerdi , M Chehelgerdi , OQB Allela , ... , R Akhavan-Sigari
Molecular Cancer2023 - VOLUME 22, ISSUE 1 p 169.
71 325
D Pradella , C Naro , C Sette , C Ghigna
Molecular Cancer2017 - VOLUME 16, ISSUE 1 p 8.
176 246
NP Shirsath , SM Manohar , KS Joshi
Molecular Cancer2012 - VOLUME 11, ISSUE 1 p 77.
19 24
M Federico , CE Symonds , L Bagella , ... , A Giordano
Molecular Cancer2010 - VOLUME 9, ISSUE 1 p 208.
7 47
DK Chang , RJ Moniz , Z Xu , ... , WA Marasco
Molecular Cancer2015 - VOLUME 14, ISSUE 1 p 119.
41 60